Marquette Asset Management, LLC Assembly Biosciences, Inc. Transaction History

Marquette Asset Management, LLC

  • $629 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
BUY
$0.65 - $1.25 $35,401 - $68,080
54,464 New
54,464 $44,000
Q1 2022

Apr 26, 2022
BUY
$1.46 - $2.45 $14,959 - $25,102
10,246 Added 21.35%
58,246 $120,000
Q4 2021

Jan 19, 2022
BUY
$2.13 - $3.46 $43,364 - $70,442
20,359 Added 73.66%
48,000 $112,000
Q3 2021

Oct 12, 2021
BUY
$3.14 - $3.9 $15,543 - $19,305
4,950 Added 21.81%
27,641 $96,000
Q2 2021

Jul 19, 2021
BUY
$3.8 - $4.56 $86,225 - $103,470
22,691 New
22,691 $88,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email